NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,593,571 | -41.1% | 713,979 | -35.2% | 0.03% | -40.0% |
| Q2 2023 | $53,640,206 | -34.1% | 1,102,347 | -24.9% | 0.06% | -36.8% |
| Q1 2023 | $81,446,507 | +32.6% | 1,466,976 | -4.0% | 0.09% | +27.9% |
| Q4 2022 | $61,402,497 | -11.4% | 1,528,566 | -3.4% | 0.07% | -18.1% |
| Q3 2022 | $69,326,000 | +10.4% | 1,582,059 | -10.7% | 0.08% | +12.2% |
| Q2 2022 | $62,802,000 | +9.1% | 1,772,067 | +25.2% | 0.07% | +37.0% |
| Q1 2022 | $57,577,000 | +327.3% | 1,415,357 | +881.0% | 0.05% | +390.9% |
| Q4 2021 | $13,475,000 | -73.0% | 144,283 | -67.8% | 0.01% | -75.6% |
| Q3 2021 | $49,950,000 | -45.5% | 448,224 | -44.4% | 0.04% | -43.0% |
| Q2 2021 | $91,570,000 | -13.1% | 806,572 | -22.2% | 0.08% | -22.5% |
| Q1 2021 | $105,334,000 | +56.0% | 1,037,369 | +52.9% | 0.10% | +70.0% |
| Q4 2020 | $67,504,000 | +48.0% | 678,296 | +7.4% | 0.06% | +27.7% |
| Q3 2020 | $45,603,000 | +63.0% | 631,271 | +12.5% | 0.05% | +42.4% |
| Q2 2020 | $27,981,000 | +397.5% | 561,183 | +198.0% | 0.03% | +266.7% |
| Q1 2020 | $5,624,000 | +531.2% | 188,345 | +482.9% | 0.01% | +800.0% |
| Q2 2019 | $891,000 | -74.6% | 32,309 | -81.0% | 0.00% | -80.0% |
| Q1 2019 | $3,506,000 | +118.4% | 170,038 | +47.9% | 0.01% | +150.0% |
| Q4 2018 | $1,605,000 | -59.8% | 114,952 | -31.0% | 0.00% | -60.0% |
| Q3 2018 | $3,990,000 | +3.9% | 166,684 | -18.3% | 0.01% | 0.0% |
| Q2 2018 | $3,841,000 | +31.1% | 204,113 | -35.4% | 0.01% | +25.0% |
| Q1 2018 | $2,929,000 | -0.8% | 315,949 | -3.8% | 0.00% | 0.0% |
| Q4 2017 | $2,953,000 | -16.6% | 328,509 | +19.6% | 0.00% | -20.0% |
| Q3 2017 | $3,539,000 | +96.0% | 274,565 | +65.1% | 0.01% | +66.7% |
| Q2 2017 | $1,806,000 | +70.9% | 166,304 | +39.5% | 0.00% | +50.0% |
| Q1 2017 | $1,057,000 | -55.6% | 119,235 | -41.4% | 0.00% | -50.0% |
| Q4 2016 | $2,382,000 | +354.6% | 203,434 | +331.2% | 0.00% | +300.0% |
| Q3 2016 | $524,000 | +12.0% | 47,183 | +21.6% | 0.00% | 0.0% |
| Q2 2016 | $468,000 | +19.1% | 38,792 | -6.1% | 0.00% | 0.0% |
| Q1 2016 | $393,000 | – | 41,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |